148 related articles for article (PubMed ID: 6143298)
1. Involvement of dynorphin and the kappa opioid receptor in feeding.
Morley JE; Levine AS
Peptides; 1983; 4(6):797-800. PubMed ID: 6143298
[TBL] [Abstract][Full Text] [Related]
2. Endorphins and food intake: kappa opioid receptor agonists and hyperphagia.
Cooper SJ; Jackson A; Kirkham TC
Pharmacol Biochem Behav; 1985 Nov; 23(5):889-901. PubMed ID: 2867562
[TBL] [Abstract][Full Text] [Related]
3. Dynorphin A and related peptides administered intrathecally in the rat: a search for putative kappa opiate receptor activity.
Stevens CW; Yaksh TL
J Pharmacol Exp Ther; 1986 Sep; 238(3):833-8. PubMed ID: 2875172
[TBL] [Abstract][Full Text] [Related]
4. The kappa agonists PD117302 and U50488 produce a biphasic effect on 24 hour food intake in the rat.
Hewson G; Hill RG; Hughes J; Leighton GE; Turner WD
Neuropharmacology; 1987 Nov; 26(11):1581-4. PubMed ID: 2829048
[TBL] [Abstract][Full Text] [Related]
5. Different motor actions of dynorphins and nonpeptide kappa opioid receptor agonists in the isolated rat colon.
Scheurer U; Wenger F; Caliezi A; Drack E; Varga L; Halter F
J Pharmacol Exp Ther; 1990 Mar; 252(3):1324-30. PubMed ID: 1969475
[TBL] [Abstract][Full Text] [Related]
6. Identification of opioid receptors on gastric muscle cells by selective receptor protection.
Grider JR; Makhlouf GM
Am J Physiol; 1991 Jan; 260(1 Pt 1):G103-7. PubMed ID: 1670978
[TBL] [Abstract][Full Text] [Related]
7. The selective kappa-opioid agonist, U-50,488H, produces antinociception in the rat via a supraspinal action.
Czlonkowski A; Millan MJ; Herz A
Eur J Pharmacol; 1987 Oct; 142(1):183-4. PubMed ID: 2826175
[No Abstract] [Full Text] [Related]
8. Early ontogeny of kappa-opioid receptor regulation of prolactin secretion in the rat.
Bero LA; Lurie SN; Kuhn CM
Brain Res; 1987 Dec; 465(1-2):189-96. PubMed ID: 2894234
[TBL] [Abstract][Full Text] [Related]
9. Kappa agonists inhibit gastric emptying but not acid secretion in rhesus monkeys.
Touzeau PL; Shea-Donohue T
J Pharmacol Exp Ther; 1990 Jun; 253(3):1010-6. PubMed ID: 1972746
[TBL] [Abstract][Full Text] [Related]
10. Effects of U50,488, a selective kappa agonist, on atypical mouse opiate systems.
Marrazzi MA; Lawhorn J; Graham V; L'Abbe D; Mullings-Britton J; Stack L; Eccles T
Brain Res Bull; 1990 Jul; 25(1):199-201. PubMed ID: 2169965
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal administration of dynorphin A and its fragments increase heart rate and arterial pressure in the urethane anesthetized rat: mediation by a nonopioid mechanism.
Rochford J; Godin C; Henry JL
Brain Res; 1991 Nov; 565(1):67-77. PubMed ID: 1685349
[TBL] [Abstract][Full Text] [Related]
12. [D-Pro10]Dynorphin-(1-11) is a highly potent and selective ligand for kappa opioid receptors.
Gairin JE; Gouarderes C; Mazarguil H; Alvinerie P; Cros J
Eur J Pharmacol; 1984 Nov; 106(2):457-8. PubMed ID: 6152222
[No Abstract] [Full Text] [Related]
13. Effects of intracerebroventricularly administered mu-, delta- and kappa-opioid agonists on locomotor activity of the guinea pig and the pharmacology of the locomotor response to U50,488H.
Bot G; Chahl LA; Brent PJ; Johnston PA
Neuropharmacology; 1992 Sep; 31(9):825-33. PubMed ID: 1359440
[TBL] [Abstract][Full Text] [Related]
14. Dynorphin selectively augments the M-current in hippocampal CA1 neurons by an opiate receptor mechanism.
Madamba SG; Schweitzer P; Siggins GR
J Neurophysiol; 1999 Oct; 82(4):1768-75. PubMed ID: 10515966
[TBL] [Abstract][Full Text] [Related]
15. Mu-, delta-, kappa- and epsilon-opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides.
Iyengar S; Kim HS; Wood PL
Brain Res; 1987 Dec; 435(1-2):220-6. PubMed ID: 2892574
[TBL] [Abstract][Full Text] [Related]
16. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
Fox DA; Burks TF
J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
[TBL] [Abstract][Full Text] [Related]
17. Effects of preferential delta and kappa opioid receptor agonists on the intake of hypotonic saline.
Gosnell BA; Majchrzak MJ; Krahn DD
Physiol Behav; 1990 Mar; 47(3):601-3. PubMed ID: 1972796
[TBL] [Abstract][Full Text] [Related]
18. Intrathecal dynorphins suppress hindlimb electromyographic activity in rats.
Stevens CW; Weinger MB; Yaksh TL
Eur J Pharmacol; 1987 Jun; 138(2):299-302. PubMed ID: 2887441
[TBL] [Abstract][Full Text] [Related]
19. Role of dynorphin-containing neurons in the presynaptic inhibitory control of the acetylcholine-evoked release of dopamine in the striosomes and the matrix of the cat caudate nucleus.
Gauchy C; Desban M; Krebs MO; Glowinski J; Kemel ML
Neuroscience; 1991; 41(2-3):449-58. PubMed ID: 1678500
[TBL] [Abstract][Full Text] [Related]
20. Behavioral effects of systemically administered mu and kappa opioid agonists in the squirrel monkey: peptides versus alkaloids.
Jones DN; Holtzman SG
Pharmacol Biochem Behav; 1994 Mar; 47(3):421-6. PubMed ID: 7911572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
